Incyte Corporation (INCY) Stock Forecast
INCY analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.75 / 5 from 28 analysts
- Price target
- $129.50 average of analyst targets
- Upside to target
- +14.5% from the latest close
- Next earnings
- October 29, 2026 EPS estimate $-3.87
- 52-week range
- $86.17 – $129.93
INCY analyst ratings
28 analystsNumber of analysts at each rating.
INCY price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
INCY earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$3.84 | −$4.46 | −$2.85 | $2.26 | −269.7% | 15 |
| Current fiscal year (2026) | $3.12 | $2.31 | $4.15 | $6.80 | −54.1% | 19 |
| Next fiscal year (2027) | $8.68 | $7.53 | $9.73 | $3.12 | +178.1% | 20 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
INCY revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.48B | $1.45B | $1.53B | +8.0% | 20 |
| Current fiscal year (2026) | $5.94B | $5.86B | $6.05B | +15.5% | 23 |
| Next fiscal year (2027) | $6.25B | $5.99B | $6.79B | +5.2% | 22 |
INCY EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
INCY revenue: reported and forecast
INCY EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$3.47 | −$3.44 | −$3.47 | −$3.67 | −$3.84 | +10.7% | 0 up · 2 down |
| Current fiscal year (2026) | $2.66 | $3.51 | $3.46 | $3.24 | $3.12 | +17.2% | 0 up · 3 down |
| Next fiscal year (2027) | $8.72 | $8.91 | $8.89 | $8.73 | $8.68 | −0.5% | 0 up · 5 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
INCY earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; INCY beat in 6 of 12.
What analysts expect from INCY
28 analysts cover Incyte; their consensus rating is buy (3.75 on a 1–5 scale, where 5 is a strong buy). The average price target is $129.50, 14.5% above the latest close of $113.07. Analysts expect earnings of $3.12 per share for 2026, −54.1% from a year earlier. For 2027 the average estimate is $8.68 per share on revenue of $6.2 billion. Incyte beat the EPS estimate in 6 of the last 12 quarters.
Related: INCY income statement, INCY key metrics, INCY chart. See the INCY stock overview for the latest quote and news.
INCY forecast FAQ
What is Incyte's price target?
The average analyst price target for Incyte is $129.50, 14.5% above the latest close of $113.07.
Is Incyte a buy, hold or sell?
Of 28 analysts covering Incyte, 10 rate it a strong buy, 2 a buy, 15 a hold, 1 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Incyte's EPS forecast?
Analysts forecast $3.12 per share for 2026 (range $2.31 to $4.15); for 2027 the estimate is $8.68.
What is Incyte's revenue forecast?
The average revenue estimate for 2026 is $5.9 billion, growth of 15.5%; for 2027 it is $6.2 billion.
When does Incyte report earnings?
Incyte is expected to report results for the quarter ending September 30, 2026 on October 29, 2026 before the market opens; the EPS estimate is $-3.87.
Does Incyte usually beat earnings estimates?
Incyte reported EPS at or above the analyst estimate in 6 of the last 12 quarters.